Pfizer Process 1 vs Process 2: Manufacturing Changes and Risks
When Pfizer switched from clinical trial production to mass manufacturing, they changed everything from DNA templates to purification methods. Internal emails reveal regulators were alarmed by unexpected DNA contaminants with known risks, while patent documents show manufacturers long understood these dangers.